Analytical results for NDMA tested medicinal products with sartans
Analytical results to date for the proprietary medicinal products containing the active substances valsartan, losartan, olmesartan, candesartan and irbesartan (status on 2 November 2018).
Medicinal products with the active substance valsartan tested for NDMA
| Medicinal product |
Authorisation number |
| Amlodipin-Valsartan-Mepha Lactab |
65866 |
| Co-Diovan |
54470 |
| Co-Valsartan Sandoz |
61874 |
| Co-Valtan-Mepha |
59321 |
| Diovan |
55743 |
| Entresto |
65673 |
| Exforge |
59407 |
| Exforge HCT |
57771 |
| Valsartan Sandoz |
62039 |
| Valtan-Mepha |
59513 |
All tested products satisfied the quality requirements.
Medicinal products with the active substance losartan tested for NDMA
| Medicinal product |
Authorisation number |
| Losartan-Mepha |
58764 |
| Cosaar Plus |
53629 |
| Losartan-HCT-Mepha |
58787 |
| Losartan Axapharm |
58981 |
| Losartan HCT Axapharm |
62109 |
| Cosaar |
52904 |
| Co-Losartan Spirig HC |
58485 |
| Losartan Spirig HC |
58486 |
| Co-Losartan Sandoz |
57885 |
| Losartan Sandoz |
58293 |
| Losartan Helvepharm |
60234 |
| Losartan HCT Helvepharm |
61314 |
All tested products satisfied the quality requirements.
Medicinal products with the active substance olmesartan tested for NDMA
| Medicinal product |
Authorisation number |
| Olmesartan-Amlodipin-Mepha |
66103 |
| Olmesartan-HCT-Mepha |
65896 |
| Olmesartan-Mepha |
65987 |
| Sevikar |
58778 |
| Sevikar HCT |
61519 |
| Olmesartan Spirig HC |
66013 |
| Co-Olmesartan Spirig HC |
66014 |
| Olmesartan Amlo Spirig HC |
66520 |
| Olmesartan Plus Sandoz |
65935 |
| Olmesartan Amlodipin Sandoz |
66468 |
| Olmesartan Sandoz |
65933 |
| Vascord HCT |
62309 |
| Vascord |
59270 |
| Votum plus |
57554 |
| Votum |
57142 |
| Olmetec Plus |
57038 |
| Olmetec |
55907 |
All tested products satisfied the quality requirements.
Medicinal products with the active substance candesartan tested for NDMA
| Medicinal product |
Authorisation number |
| Atacand plus |
54875 |
| Atacand |
54230 |
| Blopress Plus |
55247 |
| Blopress |
54260 |
| Candesartan HCT Helvepharm |
62321 |
| Candesartan Helvepharm |
62319 |
| Candesartan Plus Takeda |
62570 |
| Candesartan Sandoz |
58670 |
| Candesartan Spirig HC |
66096 |
| Candesartan Takeda |
62569 |
| Candesartan-Mepha |
60929 |
| Co-Candesartan Sandoz |
61492 |
| Co-Candesartan Spirig HC |
65930 |
| Pemzek PLUS |
62499 |
| Pemzek |
62498 |
| Cansartan-Mepha plus |
61215 |
All tested products satisfied the quality requirements.
Medicinal products with the active substance irbesartan tested for NDMA
| Medicinal product |
Authorisation number |
Aprovel, film-coated tablets
|
54250
|
Co-Irbesartan Sandoz, film-coated tablets
|
62640 |
| Co-Irbesartan Spirig HC, film-coated tablets |
62743 |
| CoAprovel, film-coated tablets |
54842 |
| Irbesartan HCT Zentiva, film-coated tablets |
62278 |
| Irbesartan-Mepha, film-coated tablets |
61511 |
Irbesartan-HCT-Mepha, Lactab
|
61497 |
| Irbesartan Sandoz, film-coated tablets |
59183 |
Irbesartan Spirig HC, film-coated tablets
|
62410 |
| Irbesartan Zentiva, film-coated tablets |
62280
|
All tested products satisfied the quality requirements.
